{"id":"https://openalex.org/W2000275011","doi":"https://doi.org/10.1016/s0378-5173(97)00108-7","title":"Effect of vehicles on topical delivery of 5-fluorouracil (5FU) by 1-acyl-5FU prodrugs","display_name":"Effect of vehicles on topical delivery of 5-fluorouracil (5FU) by 1-acyl-5FU prodrugs","publication_year":1997,"publication_date":"1997-08-01","ids":{"openalex":"https://openalex.org/W2000275011","doi":"https://doi.org/10.1016/s0378-5173(97)00108-7","mag":"2000275011"},"language":"en","primary_location":{"id":"doi:10.1016/s0378-5173(97)00108-7","doi":"https://doi.org/10.1016/s0378-5173(97)00108-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(97)00108-7","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084423369","display_name":"Ana I Patrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana I Patrick","raw_affiliation_strings":["Department of Medicinal Chemistry, P.O. Box 100\u2008485, University of Florida, Gainesville, FL 32610, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, P.O. Box 100\u2008485, University of Florida, Gainesville, FL 32610, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064269569","display_name":"Howard D. Beall","orcid":"https://orcid.org/0000-0001-8601-1496","observed_orcids":["https://orcid.org/0000-0001-8601-1496"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard D Beall","raw_affiliation_strings":["Department of Medicinal Chemistry, P.O. Box 100\u2008485, University of Florida, Gainesville, FL 32610, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, P.O. Box 100\u2008485, University of Florida, Gainesville, FL 32610, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041758732","display_name":"Patricia Gilroy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Gilroy","raw_affiliation_strings":["Department of Medicinal Chemistry, P.O. Box 100\u2008485, University of Florida, Gainesville, FL 32610, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, P.O. Box 100\u2008485, University of Florida, Gainesville, FL 32610, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112449017","display_name":"Kenneth B. Sloan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kenneth B Sloan","raw_affiliation_strings":["Department of Medicinal Chemistry, P.O. Box 100\u2008485, University of Florida, Gainesville, FL 32610, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, P.O. Box 100\u2008485, University of Florida, Gainesville, FL 32610, USA","institution_ids":["https://openalex.org/I33213144"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112449017"],"corresponding_institution_ids":["https://openalex.org/I33213144"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.8331,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.64634963,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"154","issue":"1","first_page":"39","last_page":"48"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9950000047683716},{"id":"https://openalex.org/keywords/topical-drug-delivery","display_name":"topical drug delivery","score":0.9160000085830688},{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.8220000267028809},{"id":"https://openalex.org/keywords/dermal-drug-delivery","display_name":"dermal drug delivery","score":0.8080000281333923},{"id":"https://openalex.org/keywords/solubility-parameter","display_name":"solubility parameter","score":0.9169999957084656},{"id":"https://openalex.org/keywords/isopropyl-myristate","display_name":"isopropyl myristate","score":0.8119999766349792},{"id":"https://openalex.org/keywords/miglyol-812","display_name":"Miglyol 812","score":0.9470000267028809},{"id":"https://openalex.org/keywords/tributyrin","display_name":"tributyrin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/triacetin","display_name":"triacetin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/skin-damage","display_name":"skin damage","score":0.6389999985694885},{"id":"https://openalex.org/keywords/hairless-mouse-skin","display_name":"hairless mouse skin","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.9756991863250732},{"id":"https://openalex.org/C2779783494","wikidata":"https://www.wikidata.org/wiki/Q416222","display_name":"Isopropyl myristate","level":2,"score":0.8981719017028809},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7089110612869263},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.6674540042877197},{"id":"https://openalex.org/C2778855143","wikidata":"https://www.wikidata.org/wiki/Q4116129","display_name":"Tributyrin","level":4,"score":0.42623600363731384},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33381789922714233},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2303866744041443},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13402479887008667},{"id":"https://openalex.org/C2779697368","wikidata":"https://www.wikidata.org/wiki/Q380967","display_name":"Lipase","level":3,"score":0.06852537393569946},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.05935189127922058},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0378-5173(97)00108-7","doi":"https://doi.org/10.1016/s0378-5173(97)00108-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(97)00108-7","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W393027293","https://openalex.org/W1524526859","https://openalex.org/W1742102714","https://openalex.org/W1969027250","https://openalex.org/W1974078109","https://openalex.org/W1974437354","https://openalex.org/W1980977381","https://openalex.org/W1983942257","https://openalex.org/W1991343218","https://openalex.org/W2005787232","https://openalex.org/W2010573035","https://openalex.org/W2016969647","https://openalex.org/W2042744464","https://openalex.org/W2046303682","https://openalex.org/W2066483886","https://openalex.org/W2071383312","https://openalex.org/W2071953730","https://openalex.org/W2081766813","https://openalex.org/W2118372038","https://openalex.org/W2460489907","https://openalex.org/W2461461606","https://openalex.org/W2527608309","https://openalex.org/W4252111711","https://openalex.org/W4285719527","https://openalex.org/W6718759994","https://openalex.org/W6727901356"],"related_works":["https://openalex.org/W1981173744","https://openalex.org/W4246062053","https://openalex.org/W2165828280","https://openalex.org/W2081766813","https://openalex.org/W2015508543","https://openalex.org/W2071953730","https://openalex.org/W4252111711","https://openalex.org/W2019932867","https://openalex.org/W1581088900","https://openalex.org/W2054384204"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}